Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/2059
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorCARDOSO, Elaine Cristina-
dc.contributor.authorPEREIRA, Natalli Zanete-
dc.contributor.authorMITSUNARI, Gabrielle Eimi-
dc.contributor.authorOLIVEIRA, Luanda Mara da Silva-
dc.contributor.authorRUOCCO, Rosa Maria S. A.-
dc.contributor.authorFRANCISCO, Rossana Pulcineli Vieira-
dc.contributor.authorZUGAIB, Marcelo-
dc.contributor.authorDUARTE, Alberto Jose da Silva-
dc.contributor.authorSATO, Maria Notomi-
dc.date.accessioned2013-09-23T16:42:01Z-
dc.date.available2013-09-23T16:42:01Z-
dc.date.issued2013-
dc.identifier.citationPLOS ONE, v.8, n.6, article ID e67036, 11p, 2013-
dc.identifier.issn1932-6203-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/2059-
dc.description.abstractMother-to-child transmission (MTCT) of HIV-1 has been significantly reduced with the use of antiretroviral therapies, resulting in an increased number of HIV-exposed uninfected infants. The consequences of HIV infection on the innate immune system of both mother-newborn are not well understood. In this study, we analyzed peripheral blood and umbilical cord blood (CB) collected from HIV-1-infected and uninfected pregnant women. We measured TNF-alpha, IL-10 and IFN-alpha secretion after the stimulation of the cells with agonists of both extracellular Toll-like receptors (TLRs) (TLR2, TLR4 and TLR5) and intracellular TLRs (TLR7, TLR7/8 and TLR9). Moreover, as an indicator of the innate immune response, we evaluated the responsiveness of myeloid dendritic cells (mDCs) and plasmacytoid DCs (pDCs) to TLRs that are associated with the antiviral response. Our results showed that peripheral blood mononuclear cells (PBMCs) from HIV-1-infected mothers and CB were defective in TNF-alpha production after activation by TLR2, TLR5, TLR3 and TLR7. However, the TNF-alpha response was preserved after TLR7/8 (CL097) stimulation, mainly in the neonatal cells. Furthermore, only CL097 activation was able to induce IL-10 and IFN-alpha secretion in both maternal and CB cells in the infected group. An increase in IFN-alpha secretion was observed in CL097-treated CB from HIV-infected mothers compared with control mothers. The effectiveness of CL097 stimulation was confirmed by observation of similar mRNA levels of interferon regulatory factor-7 (IRF-7), IFN-alpha and TNF-alpha in PBMCs of both groups. The function of both mDCs and pDCs was markedly compromised in the HIV-infected group, and although TLR7/TLR8 activation overcame the impairment in TNF-alpha secretion by mDCs, such stimulation was unable to reverse the dysfunctional type I IFN response by pDCs in the HIV-infected samples. Our findings highlight the dysfunction of innate immunity in HIV-infected mother-newborn pairs. The activation of the TLR7/8 pathway could function as an adjuvant to improve maternal-neonatal innate immunity.-
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/55962-3]-
dc.description.sponsorshipLaboratorio de Investigacao Medica, Unidade 56 do Hospital das Clinicas da Faculdade de Medicina de Sao Paulo (FMUSP-HC/LIM-56)-
dc.language.isoeng-
dc.publisherPUBLIC LIBRARY SCIENCE-
dc.relation.ispartofPlos One-
dc.rightsopenAccess-
dc.subject.otheractive antiretroviral therapy-
dc.subject.othercellular immune-responses-
dc.subject.otherinnate immunity-
dc.subject.othermicrobial translocation-
dc.subject.otheruninfected infants-
dc.subject.othertype-1 infection-
dc.subject.otherearly-life-
dc.subject.otherin-utero-
dc.subject.otherblood-
dc.subject.otherexpression-
dc.titleTLR7/TLR8 Activation Restores Defective Cytokine Secretion by Myeloid Dendritic Cells but Not by Plasmacytoid Dendritic Cells in HIV-Infected Pregnant Women and Newborns-
dc.typearticle-
dc.rights.holderCopyright PUBLIC LIBRARY SCIENCE-
dc.identifier.doi10.1371/journal.pone.0067036-
dc.identifier.pmid23826189-
dc.subject.wosMultidisciplinary Sciences-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalCARDOSO, Elaine Cristina:Univ Sao Paulo, Sch Med, Dept Dermatol, Lab Dermatol & Immunodeficiencies, Sao Paulo, Brazil-
hcfmusp.author.externalPEREIRA, Natalli Zanete:Univ Sao Paulo, Sch Med, Dept Dermatol, Lab Dermatol & Immunodeficiencies, Sao Paulo, Brazil-
hcfmusp.author.externalOLIVEIRA, Luanda Mara da Silva:Univ Sao Paulo, Sch Med, Dept Dermatol, Lab Dermatol & Immunodeficiencies, Sao Paulo, Brazil-
hcfmusp.description.articlenumbere67036-
hcfmusp.description.issue6-
hcfmusp.description.volume8-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84879546160-
hcfmusp.origem.idWOS:000321150000021-
hcfmusp.publisher.citySAN FRANCISCO-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceAdkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394-
hcfmusp.relation.referenceAgangi Annalisa, 2005, BJOG, V112, P881-
hcfmusp.relation.referenceAngelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea-
hcfmusp.relation.referenceBarron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957-
hcfmusp.relation.referenceBenito Jose Miguel, 2005, JAIDS Journal of Acquired Immune Deficiency Syndromes, V38, P373, DOI 10.1097/01.qai.0000153105.42455.c2-
hcfmusp.relation.referenceBoasso A, 2011, BLOOD, V118, P5152, DOI 10.1182/blood-2011-03-344218-
hcfmusp.relation.referenceBrenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511-
hcfmusp.relation.referenceBurlingham WJ, 2009, NEW ENGL J MED, V360, P1355, DOI 10.1056/NEJMcibr0810752-
hcfmusp.relation.referenceCaron JE, 2010, NEONATOLOGY, V97, P266, DOI 10.1159/000255165-
hcfmusp.relation.referenceCharrier E, 2012, CELL IMMUNOL, V276, P114, DOI [10.1016/j.cellimm.2012.04.010, 10.1016/j.cellimm.2012.02.04.010]-
hcfmusp.relation.referenceChehimi J, 2002, J IMMUNOL, V168, P4796-
hcfmusp.relation.referenceDanis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760-
hcfmusp.relation.referenceDauby N, 2012, LANCET INFECT DIS, V12, P330, DOI 10.1016/S1473-3099(11)70341-3-
hcfmusp.relation.referencede Brito CA, 2009, IMMUNOTHERAPY, V1, P883, DOI [10.2217/imt.09.38, 10.2217/IMT.09.38]-
hcfmusp.relation.referenceDesai S, 2007, JAIDS-J ACQ IMM DEF, V45, P501, DOI 10.1097/QAI.0b013e3180654811-
hcfmusp.relation.referenceDiebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616-
hcfmusp.relation.referenceDolcini G, 2003, AIDS RES HUM RETROV, V19, P857, DOI 10.1089/088922203322493021-
hcfmusp.relation.referenceDonaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189-
hcfmusp.relation.referenceFutata EA, 2012, EXPERT REV ANTI-INFE, V10, P289, DOI [10.1586/eri.12.9, 10.1586/ERI.12.9]-
hcfmusp.relation.referenceGringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858-
hcfmusp.relation.referenceHeikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987-
hcfmusp.relation.referenceHonda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547-
hcfmusp.relation.referenceIzaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255-
hcfmusp.relation.referenceKamga I, 2005, J INFECT DIS, V192, P303, DOI 10.1086/430931-
hcfmusp.relation.referenceKoyanagi A, 2011, PEDIATR INFECT DIS J, V30, P45, DOI 10.1097/INF.0b013e3181ecbf7e-
hcfmusp.relation.referenceKuhn L, 2002, CLIN INFECT DIS, V34, P267, DOI 10.1086/338153-
hcfmusp.relation.referenceKuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029-
hcfmusp.relation.referenceLegrand FA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000102-
hcfmusp.relation.referenceLester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35-
hcfmusp.relation.referenceLevy O, 2004, J IMMUNOL, V173, P4627-
hcfmusp.relation.referenceLevy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075-
hcfmusp.relation.referenceLevy O, 2006, BLOOD, V108, P1284, DOI 10.1182/blood-2005-12-4821-
hcfmusp.relation.referenceLivak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262-
hcfmusp.relation.referenceLohman-Payne B, 2010, CLIN PERINATOL, V37, P787, DOI 10.1016/j.clp.2010.08.005-
hcfmusp.relation.referenceLund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101-
hcfmusp.relation.referenceMarchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29-
hcfmusp.relation.referenceMeier A, 2007, EXPERT REV ANTI-INFE, V5, P323, DOI 10.1586/14787210.5.3.323-
hcfmusp.relation.referenceMogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54-
hcfmusp.relation.referenceMold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511-
hcfmusp.relation.referenceMorgado JM, 2008, TRANSPL IMMUNOL, V19, P55, DOI 10.1016/j.trim.2007.11.002-
hcfmusp.relation.referenceMussi-Pinhata MM, 2007, PEDIATR INFECT DIS J, V26, P1032, DOI 10.1097/INF.0b013e31812f56ed-
hcfmusp.relation.referencePacanowski J, 2001, BLOOD, V98, P3016, DOI 10.1182/blood.V98.10.3016-
hcfmusp.relation.referencePasare C, 2004, SEMIN IMMUNOL, V16, P23, DOI 10.1016/j.smim.2003.10.006-
hcfmusp.relation.referenceReis e Sousa C, 2004, SEMIN IMMUNOL, V16, P27-
hcfmusp.relation.referenceRosenblatt HM, 2005, J INFECT DIS, V192, P445, DOI 10.1086/431597-
hcfmusp.relation.referenceROWLANDJONES SL, 1993, LANCET, V341, P860, DOI 10.1016/0140-6736(93)93063-7-
hcfmusp.relation.referenceSiegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835-
hcfmusp.relation.referenceSmed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005-
hcfmusp.relation.referenceVelilla PA, 2008, CLIN IMMUNOL, V126, P243, DOI 10.1016/j.clim.2007.11.004-
hcfmusp.relation.referenceVillacres MC, 2012, J INFECT DIS, V206, P780, DOI 10.1093/infdis/jis380-
hcfmusp.relation.referenceWarning JC, 2011, REPRODUCTION, V141, P715, DOI 10.1530/REP-10-0360-
hcfmusp.relation.referenceWillems F, 2009, EUR J IMMUNOL, V39, P26, DOI 10.1002/eji.200838391-
hcfmusp.relation.reference[Anonymous], 2012, BJOG, P1-
dc.description.indexMEDLINE-
hcfmusp.remissive.sponsorshipFAPESP-
hcfmusp.remissive.sponsorshipFMUSP-HC-
hcfmusp.citation.scopus23-
hcfmusp.scopus.lastupdate2022-08-26-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MDR
Departamento de Radiologia - FM/MDR

Artigos e Materiais de Revistas Científicas - FM/MDT
Departamento de Dermatologia - FM/MDT

Artigos e Materiais de Revistas Científicas - FM/MOG
Departamento de Obstetrícia e Ginecologia - FM/MOG

Artigos e Materiais de Revistas Científicas - FM/MPT
Departamento de Patologia - FM/MPT

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/03
LIM/03 - Laboratório de Medicina Laboratorial

Artigos e Materiais de Revistas Científicas - LIM/56
LIM/56 - Laboratório de Investigação em Dermatologia e Imunodeficiências

Artigos e Materiais de Revistas Científicas - LIM/57
LIM/57 - Laboratório de Fisiologia Obstétrica

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar

Artigos e Materiais de Revistas Científicas - ODS/05
ODS/05 - Igualdade de gênero


Files in This Item:
File Description SizeFormat 
art_MITSUNARI_TLR7_TLR8_Activation_Restores_Defective_Cytokine_Secretion_by_2013.PDFpublishedVersion (English)3.39 MBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.